- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Smoldering Multiple Myeloma (SMM) in United Kingdom
Total 2105 results
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Tufts Medical CenterNational Cancer Institute (NCI)Not yet recruitingSmoldering Multiple MyelomaUnited States
-
University of SouthamptonNIHR Clinical Research Facility, University Hospital Southampton NHS Foundation... and other collaboratorsTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Gilead SciencesCompletedChronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Lymphoma, Non-Hodgkin (NHL)United States
-
HealthTree FoundationGlaxoSmithKlineRecruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma | CoronavirusUnited States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Tufts Medical CenterNational Institute on Aging (NIA)CompletedMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
AbbVieCompletedMultiple Myeloma (MM)United States, Argentina, Australia, Brazil, Canada, Croatia, Czechia, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovenia, Spain, Taiwan, Turkey
-
Ohio State University Comprehensive Cancer CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedMultiple Myeloma Bone DiseaseUnited Kingdom, United States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationTerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; National Institute for...Completed
-
Abramson Cancer Center of the University of PennsylvaniaCompleteda Diagnosis of MGUS or SMM by IMWG CriteriaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
University College, LondonActive, not recruitingMultiple MyelomaUnited Kingdom
-
National Cancer Institute (NCI)TerminatedMyeloma, Multiple | Myeloma-MultipleUnited States
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncTerminatedRefractory Multiple Myeloma | Myeloma | Myeloma MultipleUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
St. Bartholomew's HospitalUnknownLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
Mayo ClinicCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruiting
-
All4CureGlaxoSmithKlineRecruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma, RefractoryUnited States
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
The Cleveland ClinicWithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Cancer Trials IrelandCompleted
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United KingdomActive, not recruiting
-
Michael A. Thompson, MD, PhDVince Lombardi Cancer ClinicCompletedMultiple Myeloma | Myeloma, Multiple | Myeloma-MultipleUnited States
-
Alfred Chung, MDMerck Sharp & Dohme LLCTerminatedMultiple Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Marshall UniversityEdwards Foundation, Inc.TerminatedChronic Lymphocytic Leukemia | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Mundipharma-EDO GmbHTerminatedMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma ProgressionSwitzerland, United States, Norway
-
Novartis PharmaceuticalsCompletedRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Relapsed and Bortezomib Refractory Multiple MyelomaUnited States
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, France, Spain
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
The Christie NHS Foundation TrustNot yet recruiting
-
Massachusetts General HospitalPfizerRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
West of Scotland Lymphoma GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Opna Bio LLCNot yet recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Medical College of WisconsinRecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States